GPRC5D and Miyoshi myopathy: Studies have confirmed that GPRC5d is consistently expressed on MM cells with a membranous pattern and is absent from nearly all healthy tissues, with the exception of the hair follicle, making it an ideal target for anti-myeloma therapy (50).